#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Denmark France Germany Italy +5

  • Study on the Safety of MB-CART19.1 for Patients with Active Systemic Lupus Erythematosus, Systemic Sclerosis, or Dermatomyositis/Polymyositis

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

    Recruiting

    2 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +4

  • Study on the Safety of Allogeneic Adipose-Derived Mesenchymal Stromal Cells for Patients with Severe Systemic Sclerosis

    Recruiting

    2 1
    Investigated drugs:
    France

  • Study on the Effects of Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Finland France Germany Greece +2

  • Study on Treating Calcinosis Cutis in Systemic Sclerosis Patients with Sodium Thiosulfate, Cetrimide, and Lidocaine

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Use of Allogenic Adipose-Tissue-Derived Mesenchymal Stem Cells for Healing Chronic Digital Ulcers in Systemic Sclerosis Patients

    Recruiting

    2 1
    France

  • Study on Mesenchymal Stem Cells for Patients with Systemic Sclerosis and Digital Ulcers

    Recruiting

    2 1
    Investigated drugs:
    The Netherlands

  • Rituximab versus placebo for maintenance therapy in adults with stabilized systemic sclerosis‑associated interstitial lung disease

    Not yet recruiting

    4 1 1
    Investigated drugs:
    France

  • Lebrikizumab in Adults with Moderate to Severe Localized Scleroderma

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany